Corrigendum to “Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme” [Int. J. Infect. Dis. 97 (2020) 182–189]
Anai García Fariñas,
Nivaldo Linares-Pérez,
Andrew Clark,
María Eugenia Toledo-Romaní,
Nathalie El Omeiri,
Martha C. Marrero Araújo,
Isabel Pilar Gonzálvez Luis,
Gilda Toraño Peraza,
Alicia Reyes Jiménez,
Lena López Ambrón
Affiliations
Anai García Fariñas
Finlay Vaccine Institute, Havana, Cuba; Corresponding author.
Nivaldo Linares-Pérez
Finlay Vaccine Institute, Havana, Cuba
Andrew Clark
London School of Hygiene & Tropical Medicine, London, United Kingdom
María Eugenia Toledo-Romaní
Institute of Tropical Medicine Pedro Kouri, Havana, Cuba
Nathalie El Omeiri
Pan American Health Organization, Washington, D.C., USA
Martha C. Marrero Araújo
National School of Public Health, Havana, Cuba
Isabel Pilar Gonzálvez Luis
Finlay Vaccine Institute, Havana, Cuba
Gilda Toraño Peraza
Institute of Tropical Medicine Pedro Kouri, Havana, Cuba
Alicia Reyes Jiménez
Institute of Tropical Medicine Pedro Kouri, Havana, Cuba
